Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

DISON I - Directly Integrated Suction and Optics System for the Treatment of Nephrolithiasis

NCT: NCT07712861 · NOT_YET_RECRUITING

NCT IDNCT07712861
StatusNOT_YET_RECRUITING
Start Date2026-10
Completion2028-08
SponsorVentaris Surgical Incorporated (INDUSTRY)
First posted
Last updated

Brief Summary

A single-arm, multicenter, international, prospective interventional study designed to evaluate the safety and performance of an investigational device during retrograde intrarenal surgery for the treatment of renal calculi.

Frequently Asked Questions

What is DISON I - Directly Integrated Suction and Optics System for the Treatment of Nephrolithiasis?

DISON I - Directly Integrated Suction and Optics System for the Treatment of Nephrolithiasis is a clinical trial registered under NCT07712861. Current status: NOT_YET_RECRUITING.

What is the status of NCT07712861?

The current status of NCT07712861 (DISON I - Directly Integrated Suction and Optics System for the Treatment of Nephrolithiasis) is: NOT_YET_RECRUITING.

When did DISON I - Directly Integrated Suction and Optics System for the Treatment of Nephrolithiasis start?

DISON I - Directly Integrated Suction and Optics System for the Treatment of Nephrolithiasis started on 2026-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑